Español 
Deutsch 
Français 
MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
iBio, Inc. (IBIO)
USD1.43
-0.01 (-0.69%)
US NASDAQ Healthcare Biotechnology
Address
8800 HSC Parkway 77807
Bryan, TX, US
Bryan, TX, US
CEO
Martin Brenner
Website
ibioinc.com
IPO
2008-08-19
CIK 1420720 ISIN US4510337086
Description
iBio, Inc., a United States-based biotechnology firm, delivers contract development and manufacturing (CDMO) services to its collaborators and external clients. Its operations are structured into two distinct segments: Biopharmaceuticals and Bioprocessing. The company's leading therapeutic candidate, IBIO-100, is currently progressing through investigational new drug (IND) development, aimed at addressing systemic scleroderma and idiopathic pulmonary fibrosis. Additionally, iBio is engaged in the preclinical development of vaccine candidates, including IBIO-200 and IBIO-201, designed to prevent severe acute respiratory syndrome coronavirus 2. Another candidate, IBIO-400, is in development for the treatment of classical swine fever. Beyond its proprietary pipeline, iBio provides recombinant proteins to third parties, available both as catalog items and custom-synthesized products. It also offers comprehensive services spanning process development, advanced manufacturing, filling and finishing, and bioanalytical support. iBio maintains several strategic partnerships: a licensing agreement with Planet Biotechnology, Inc. for infectious disease therapeutics; a collaborative effort with The Texas A&M University System focused on COVID-19 vaccine candidates; a licensing pact with the University of Natural Resources and Life Sciences, Vienna; and a collaboration with CC-Pharming Ltd. Its corporate headquarters are situated in Bryan, Texas.
Market Cap & Enterprise Value
Merger & Acquisition History
No mergers or acquisitions recorded for this company.
Technical Outlook
Loading outlook…
Loading forecast...
Signal Summary
Loading…
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Each column is computed on that timeframe's candles (1D = daily, 1W ≈ weekly, 1M ≈ monthly), not on the same last day. ▲ bullish · ▼ bearish · — neutral. The Net row counts signals per column; hover any cell (or the indicator name) to see the exact rule behind it.
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
Indicative levels generated algorithmically. Not financial advice.
Risk Profile
Loading risk profile…
Price Chart
USD1.43
-0.01 (-0.69%)
Loading historical data…
Volume Profile
Loading…
Liquidity & share structure
Average Volume
932.0K
Beta
1.27
Float Shares
14.94M
Free Float %
94.6%
Price Performance
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| -3.01% | -1.83% | -26.82% | -27.48% | +40.00% | -16.58% | +101.25% | -91.44% | -99.78% | -99.95% | -99.97% |
Rolling Volatility
Loading…
Drawdown
Loading…
Relative Strength
Loading…
Monthly Returns Heatmap
From
To
Loading…
Annual Monthly Returns
Loading…
Daily Returns Distribution
Loading histogram data…
Revenue flow
Revenue by geography
Revenue by segment
From
To
Revenue composition
From
To
By product
By geography
Financial Statements
Select metrics from the tables below to build your comparison.
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
Analyst Consensus (4 ratings, all time)
Buy
Price Targets & DCF
Current price
1.43
Low
2.00
+39.9%
Consensus
2.80
+95.8%
Median
2.80
+95.8%
High
3.60
+151.7%
DCF (Unlevered)
0.24
-83.0%
DCF (Levered)
0.12
-91.7%
DCF figures are point estimates: small changes in growth or discount-rate assumptions move them materially. Read them as a reference, not a precise target.
Ratings Trend (MoM)
100% Bullish
| Rating | 2026-05 | Change |
|---|---|---|
| Strong Buy | 0 | 0 |
| Buy | 6 | 0 |
| Hold | 0 | 0 |
| Sell | 0 | 0 |
| Strong Sell | 0 | 0 |
Price Target Summary
| Period | # Analysts | Avg Target |
|---|---|---|
| Last Month | — | — |
| Last Quarter | — | — |
| Last Year | 1 |
2.00
+39.9%
|
| All Time | 2 |
2.80
+95.8%
|
Quality scores
Altman Z-Score
-3.64
Distress
Piotroski F-Score
2 / 9
Weak
MOAT Score
0 / 10
No MOAT
Composite Rating
C
Overall Score
2 / 5
Medium
DCF Score
2 / 5
Medium
ROE Score
1 / 5
Low
ROA Score
1 / 5
Low
D/E Score
3 / 5
Medium
P/E Score
1 / 5
Low
P/Book Score
2 / 5
Medium
Operational MOAT
✗ Below peers
-
Revenue growth Biotechnology: +1.6%+77.8% ★
-
EPS growth Biotechnology: +29.7%+73.1% ★ Q1'26: +87.8% (vs Q1'25)
-
FCF margin FCF growth · Biotechnology: +16.2%-4,197.0%
-
EBIT margin Biotechnology: +0.0%-4,541.3%
-
ROIC Biotechnology: -16.1%-185.2% Q1'26: +0.0% (vs Q1'25)
-
Share dilution Biotechnology: -3.4%+174.1% Q1'26: +1,112.7% (vs Q1'25)
-
Debt / EBITDA Net debt/EBITDA · Biotechnology: 0.16×-0.21×
Valuation Multiples
From
To
Price Forecast (3Y)
From
To
Theoretical Return — If Invested Today
* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.
Consensus Estimates
| Metric |
Jun 2020 actual |
Jun 2021 actual |
Jun 2022 actual |
Jun 2023 actual |
Jun 2024 actual |
Jun 2025 actual |
Jun 2026 4 Rev. Ana. 3 EPS Ana. |
Jun 2027 3 Rev. Ana. 3 EPS Ana. |
Jun 2028 2 Rev. Ana. 1 EPS Ana. |
Jun 2029 1 Rev. Ana. 1 EPS Ana. |
Jun 2030 1 Rev. Ana. 1 EPS Ana. |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue |
1.64M
est: 600.0K (+173.0%)
|
2.37M
est: 2.60M (-8.8%)
|
1.88M
est: 2.55M (-26.1%)
|
—
est: 500.0K (-100.0%)
|
225.0K
est: 25.0K (+800.0%)
|
400.0K
est: 300.0K (+33.3%)
|
180.0K
78.3K – 391.3K
-40.0% YoY
|
120.0K
92.3K – 197.8K
-33.3% YoY
|
250.0K
192.3K – 412.1K
+108.3% YoY
|
500.0K
384.6K – 824.2K
+100.0% YoY
|
500.0K
384.6K – 824.2K
+0.0% YoY
|
| EBITDA |
-11.74M
est: -360.0K (-3,160.3%)
|
-28.55M
est: -1.56M (-1,730.4%)
|
-25.72M
est: -1.53M (-1,581.2%)
|
-27.85M
est: -300.0K (-9,182.7%)
|
-14.02M
est: -15.0K (-93,373.3%)
|
-17.04M
est: -180.0K (-9,366.1%)
|
-108.0K
-234.8K – -47.0K
+40.0% YoY
|
-72.0K
-118.7K – -55.4K
+33.3% YoY
|
-150.0K
-247.3K – -115.4K
-108.3% YoY
|
-300.0K
-494.5K – -230.8K
-100.0% YoY
|
-300.0K
-494.5K – -230.8K
+0.0% YoY
|
| EBIT |
-13.98M
est: -360.0K (-3,782.8%)
|
-30.97M
est: -1.56M (-1,885.1%)
|
-29.51M
est: -1.53M (-1,829.0%)
|
-29.23M
est: -300.0K (-9,642.7%)
|
-15.27M
est: -15.0K (-101,706.7%)
|
-18.17M
est: -180.0K (-9,991.7%)
|
-108.0K
-234.8K – -47.0K
+40.0% YoY
|
-72.0K
-118.7K – -55.4K
+33.3% YoY
|
-150.0K
-247.3K – -115.4K
-108.3% YoY
|
-300.0K
-494.5K – -230.8K
-100.0% YoY
|
-300.0K
-494.5K – -230.8K
+0.0% YoY
|
| Net Income |
-16.44M
est: -3.25B (+99.5%)
|
-23.21M
est: -839.92M (+97.2%)
|
-50.39M
est: -1.10B (+95.4%)
|
-65.01M
est: -1.17B (+94.4%)
|
-24.91M
est: -77.80M (+68.0%)
|
-18.38M
est: -18.48M (+0.5%)
|
-3.20M
-3.56M – -2.85M
+82.7% YoY
|
-2.94M
-3.96M – -1.93M
+8.1% YoY
|
-4.72M
-6.84M – -2.60M
-60.2% YoY
|
-4.92M
-9.06M – -3.44M
-4.3% YoY
|
-4.82M
-8.89M – -3.38M
+1.9% YoY
|
| SGA |
11.37M
est: 11.81M (-3.7%)
|
21.89M
est: 51.16M (-57.2%)
|
17.96M
est: 50.17M (-64.2%)
|
19.02M
est: 9.84M (+93.3%)
|
11.67M
est: 491.9K (+2,273.4%)
|
10.69M
est: 5.90M (+81.1%)
|
3.54M
1.54M – 7.70M
-40.0% YoY
|
2.36M
1.82M – 3.89M
-33.3% YoY
|
4.92M
3.78M – 8.11M
+108.3% YoY
|
9.84M
7.57M – 16.22M
+100.0% YoY
|
9.84M
7.57M – 16.22M
+0.0% YoY
|
| EPS |
-304.64
est: -310.00 (+1.7%)
|
-59.98
est: -80.00 (+25.0%)
|
-2,889.06
est: -105.00 (-2,651.5%)
|
-106.18
est: -111.40 (+4.7%)
|
-6.50
est: -7.41 (+12.3%)
|
-1.75
est: -1.76 (+0.6%)
|
-0.31
-0.34 – -0.27
+82.4% YoY
|
-0.29
-0.38 – -0.18
+6.5% YoY
|
-0.35
-0.65 – -0.25
-21.8% YoY
|
-0.47
-0.86 – -0.33
-32.6% YoY
|
-0.46
-0.85 – -0.32
+1.9% YoY
|
Historical Ratings (3M)
| Date | Rating | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
| 2026-05-11 | C | 2/5 | 2/5 | 1/5 | 1/5 | 3/5 | 1/5 | 2/5 |
| 2026-05-08 | C | 2/5 | 2/5 | 1/5 | 1/5 | 3/5 | 1/5 | 2/5 |
| 2026-05-07 | C | 2/5 | 2/5 | 1/5 | 1/5 | 3/5 | 1/5 | 2/5 |
| 2026-05-06 | C | 2/5 | 2/5 | 1/5 | 1/5 | 3/5 | 1/5 | 2/5 |
| 2026-05-05 | C | 2/5 | 2/5 | 1/5 | 1/5 | 3/5 | 1/5 | 2/5 |
| 2026-05-04 | C | 2/5 | 2/5 | 1/5 | 1/5 | 3/5 | 1/5 | 2/5 |
| 2026-05-01 | C | 2/5 | 3/5 | 1/5 | 1/5 | 3/5 | 1/5 | 2/5 |
| 2026-04-30 | C | 2/5 | 3/5 | 1/5 | 1/5 | 3/5 | 1/5 | 2/5 |
| 2026-04-29 | C | 2/5 | 3/5 | 1/5 | 1/5 | 2/5 | 1/5 | 2/5 |
| 2026-04-28 | C | 2/5 | 3/5 | 1/5 | 1/5 | 2/5 | 1/5 | 2/5 |
| 2026-04-27 | C | 2/5 | 3/5 | 1/5 | 1/5 | 2/5 | 1/5 | 2/5 |
| 2026-04-24 | C | 2/5 | 3/5 | 1/5 | 1/5 | 2/5 | 1/5 | 2/5 |
| 2026-04-23 | C | 2/5 | 3/5 | 1/5 | 1/5 | 2/5 | 1/5 | 2/5 |
| 2026-04-22 | C | 2/5 | 3/5 | 1/5 | 1/5 | 2/5 | 1/5 | 2/5 |
| 2026-04-21 | C | 2/5 | 3/5 | 1/5 | 1/5 | 2/5 | 1/5 | 2/5 |
| 2026-04-20 | C | 2/5 | 3/5 | 1/5 | 1/5 | 2/5 | 1/5 | 2/5 |
| 2026-04-17 | C | 2/5 | 3/5 | 1/5 | 1/5 | 2/5 | 1/5 | 2/5 |
| 2026-04-16 | C | 2/5 | 3/5 | 1/5 | 1/5 | 2/5 | 1/5 | 2/5 |
Owner Earnings
Owner's Earnings (history)
From
To
Owner alignment
Owner's Earnings TTM
-27.17M
OE per share TTM
-1.12
Owner's Yield
-16.51%
Maintenance CapEx ratio
—
Maint CapEx / Avg PPE
1,773.0%
Ownership Overview
Ownership breakdown
At a glance
Institutional holders
8
Total invested
764.6K
Insider transactions (90d)
0
Beneficial owners (>5%)
22
Beneficial owners (>5%)
| # | Reporting person | Amount owned | % of class | Sole voting | Shared voting | Sole dispositive | Shared dispositive | Type | Citizenship | Filing date | SEC filing |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | E. Gerald Kay | 5.95M | 10.49% | 3.87M | 2.08M | 3.87M | 10.00 | IN | United States | 2013-06-13 | ↗ |
| 2 | Carl DeSantis | 5.04M | 8.89% | 6.1K | 5.03M | 6.1K | 10.00 | IN | United States | 2013-06-13 | ↗ |
| 3 | (1) BlackRock, Inc. | 3.96M | 1.80% | 3.96M | — | 3.96M | — | HC | Delaware | 2022-07-08 | ↗ |
| 4 | Christina Kay | 2.47M | 10.52% | 1.03M | 1.44M | 1.03M | 10.00 | IN | United States | 2008-08-21 | ↗ |
| 5 | Riva Kay Sheppard | 2.47M | 10.52% | 1.03M | 1.44M | 1.03M | 10.00 | IN | United States | 2008-08-21 | ↗ |
| 6 | Robert B. Kay | 2.30M | 9.80% | 211.3K | 2.09M | 211.3K | 10.00 | IN | United States | 2008-08-21 | ↗ |
| 7 | DeSantis Revocable Trust | 2.24M | 3.94% | — | 2.24M | — | 10.00 | OO | Florida | 2013-06-13 | ↗ |
| 8 | CD Financial, LLC | 1.53M | 2.70% | — | 1.53M | — | 10.00 | OO | Florida | 2013-06-13 | ↗ |
| 9 | Integrated BioPharma, Inc. | 1.27M | 5.40% | 1.27M | — | 1.27M | 10.00 | OO | Delaware | 2008-08-21 | ↗ |
| 10 | Lynx1 Capital Management LP | 878.5K | 9.99% | — | 878.5K | — | — | PN | Delaware | 2024-04-01 | ↗ |
| 11 | Weston Nichols | 878.5K | 9.99% | — | 878.5K | — | — | IN | United States of America | 2024-04-01 | ↗ |
| 12 | CDS Group Holdings, LLC | 819.6K | 3.49% | — | 819.6K | — | 10.00 | OO | Florida | 2008-08-21 | ↗ |
| 13 | EVJ, LLC | 819.6K | 3.49% | — | 819.6K | — | 10.00 | OO | Delaware | 2008-08-21 | ↗ |
| 14 | ADAR1 Capital Management GP, LLC | 789.3K | 9.27% | — | 789.3K | — | 789.3K | OO | or place of organization | 2024-04-05 | ↗ |
| 15 | ADAR1 Capital Management, LLC | 789.3K | 9.27% | — | 789.3K | — | 789.3K | OO | or place of organization | 2024-04-05 | ↗ |
| 16 | ADAR1 Partners, LP | 789.3K | 9.27% | — | 789.3K | — | 789.3K | PN | or place of organization | 2024-04-05 | ↗ |
| 17 | Daniel Schneeberger | 789.3K | 9.27% | — | 789.3K | — | 789.3K | IN | or place of organization | 2024-04-05 | ↗ |
| 18 | EGK, LLC | 778.7K | 1.37% | 778.7K | — | 778.7K | 10.00 | OO | Delaware | 2013-06-13 | ↗ |
| 19 | Ikarian Capital, LLC | 599.9K | 6.60% | — | 599.9K | — | 599.9K | IA | Delaware | 2024-11-14 | ↗ |
| 20 | Neil Shahrestani | 599.9K | 6.60% | — | 599.9K | — | 599.9K | HC, IN | Delaware | 2024-11-14 | ↗ |
| 21 | The Vanguard Group - 23-1945930 | 475.6K | 5.28% | — | — | 472.6K | 3.0K | IA | Pennsylvania For | 2023-02-09 | ↗ |
| 22 | SCHEDULE 13D/A | 12.00 | 14.00% | — | 8.63M | 10.00 | 8.63M | CO | — | 2020-08-11 | ↗ |
Institutional Activity (13F)
Institutional ownership trend
From
To
13F snapshot — 2026 Q1
Investors holding
8
-41 vs prev Q
New positions
2
Closed positions
43
Increased
4
Reduced
2
Put/Call ratio
0.00
Calls held
—
Puts held
—
Top institutional holders
| # | Investor | Shares / Δ | Mkt value / Δ | Own% / Δ | Weight% / Δ | Avg px / Perf. | Hold / Status |
|---|---|---|---|---|---|---|---|
| 1 | ECOR1 CAPITAL, LLC | 2.23M +2.2M (+100.0%) | 4.30M +4.3M (+100.0%) | 2.25% +2.248 pp | 0.20% +0.195 pp | USD1.93 +0.0% | 1 qtrs NEW |
| 2 | AFFINITY ASSET ADVISORS, LLC | 2.06M +2.1M (+100.0%) | 3.97M +4.0M (+100.0%) | 2.08% +2.075 pp | 0.23% +0.226 pp | USD1.93 +0.0% | 1 qtrs NEW |
| 3 | LOGOS GLOBAL MANAGEMENT LP | 2.00M +2.0M (+100.0%) | 3.86M +3.9M (+100.0%) | 2.02% +2.018 pp | 0.23% +0.233 pp | USD1.93 +0.0% | 1 qtrs NEW |
| 4 | FRAZIER LIFE SCIENCES MANAGEMENT, L.P. | 1.95M +2.0M (+100.0%) | 3.77M +3.8M (+100.0%) | 1.97% +1.971 pp | 0.10% +0.101 pp | USD1.93 +0.0% | 1 qtrs NEW |
| 5 | BALYASNY ASSET MANAGEMENT L.P. | 1.10M +1.1M (+10,440.2%) | 2.12M +2.1M (+24,474.6%) | 1.11% +1.007 pp | 0.00% +0.003 pp | USD1.92 +0.5% | 2 qtrs — |
| 6 | IKARIAN CAPITAL, LLC | 957.1K +339.7K (+55.0%) | 1.85M +1.3M (+261.5%) | 0.97% -4.914 pp | 0.14% +0.093 pp | USD2.80 -31.1% | 8 qtrs — |
| 7 | VANGUARD GROUP INC | 883.1K +609.1K (+222.2%) | 1.70M +1.5M (+651.1%) | 0.89% -1.720 pp | 0.00% +0.000 pp | USD1.96 -1.5% | 7 qtrs — |
| 8 | SIO CAPITAL MANAGEMENT, LLC | 740.0K +740.0K (+100.0%) | 1.43M +1.4M (+100.0%) | 0.75% +0.747 pp | 0.22% +0.225 pp | USD1.93 +0.0% | 1 qtrs NEW |
| 9 | AMERIPRISE FINANCIAL INC | 584.4K +102.1K (+21.2%) | 1.13M +728.6K (+182.5%) | 0.59% -4.004 pp | 0.00% +0.000 pp | USD1.02 +89.2% | 2 qtrs — |
| 10 | TWO SIGMA INVESTMENTS, LP | 456.3K +456.3K (+100.0%) | 880.7K +880.7K (+100.0%) | 0.46% +0.460 pp | 0.00% +0.001 pp | USD1.93 +0.0% | 1 qtrs NEW |
| 11 | ADAR1 CAPITAL MANAGEMENT, LLC | 405.5K +378.5K (+1,402.0%) | 782.7K +760.3K (+3,401.7%) | 0.41% +0.152 pp | 0.06% +0.055 pp | USD1.85 +4.3% | 8 qtrs — |
| 12 | RENAISSANCE TECHNOLOGIES LLC | 353.3K +353.3K (+100.0%) | 681.9K +681.9K (+100.0%) | 0.36% +0.356 pp | 0.00% +0.001 pp | USD1.93 +0.0% | 1 qtrs NEW |
| 13 | MONASHEE INVESTMENT MANAGEMENT LLC | 274.9K +274.9K (+100.0%) | 530.5K +530.5K (+100.0%) | 0.28% +0.277 pp | 0.30% +0.299 pp | USD1.93 +0.0% | 1 qtrs NEW |
| 14 | BOOTHBAY FUND MANAGEMENT, LLC | 254.4K +77.6K (+43.8%) | 491.0K +344.6K (+235.4%) | 0.26% -1.428 pp | 0.01% +0.005 pp | USD1.90 +1.6% | 7 qtrs — |
| 15 | HUDSON BAY CAPITAL MANAGEMENT LP | 242.1K +242.1K (+100.0%) | 467.2K +467.2K (+100.0%) | 0.24% +0.244 pp | 0.00% +0.002 pp | USD1.93 +0.0% | 1 qtrs NEW |
| 16 | NOESIS CAPITAL MANGEMENT CORP | 224.2K +224.2K (+100.0%) | 432.7K +432.7K (+100.0%) | 0.42% +0.423 pp | 0.06% +0.063 pp | USD1.93 +0.0% | 1 qtrs NEW |
| 17 | GEODE CAPITAL MANAGEMENT, LLC | 222.6K +71.3K (+47.1%) | 429.6K +304.4K (+243.0%) | 0.22% -1.217 pp | 0.00% +0.000 pp | USD1.96 -1.5% | 7 qtrs — |
| 18 | WALLEYE CAPITAL LLC | 198.4K +198.4K (+100.0%) | 382.9K +382.9K (+100.0%) | 0.20% +0.200 pp | 0.00% +0.001 pp | USD1.93 +0.0% | 1 qtrs NEW |
| 19 | JEFFERIES FINANCIAL GROUP INC. | 160.0K +160.0K (+100.0%) | 308.8K +308.8K (+100.0%) | 0.16% +0.161 pp | 0.00% +0.002 pp | USD1.93 +0.0% | 1 qtrs NEW |
| 20 | UBS GROUP AG | 126.6K +126.6K (+12,655,500.0%) | 244.3K +244.3K (+24,425,200.0%) | 0.13% +0.128 pp | 0.00% +0.000 pp | USD1.93 +0.0% | 9 qtrs — |
| 21 | MARSHALL WACE, LLP | 121.3K +121.3K (+100.0%) | 234.1K +234.1K (+100.0%) | 0.12% +0.122 pp | 0.00% +0.000 pp | USD1.93 +0.0% | 1 qtrs NEW |
| 22 | BANK OF AMERICA CORP /DE/ | 115.8K +115.6K (+79,757.2%) | 223.5K +223.4K (+186,134.2%) | 0.12% +0.115 pp | 0.00% +0.000 pp | USD1.93 +0.0% | 7 qtrs — |
| 23 | TWO SIGMA ADVISERS, LP | 108.4K +108.4K (+100.0%) | 209.2K +209.2K (+100.0%) | 0.11% +0.109 pp | 0.00% +0.000 pp | USD1.93 +0.0% | 1 qtrs NEW |
| 24 | SILVERARC CAPITAL MANAGEMENT, LLC | 106.0K +106.0K (+100.0%) | 204.6K +204.6K (+100.0%) | 0.11% +0.107 pp | 0.03% +0.028 pp | USD1.93 +0.0% | 1 qtrs NEW |
| 25 | JANE STREET GROUP, LLC | 105.7K +105.7K (+100.0%) | 204.0K +204.0K (+100.0%) | 0.11% +0.107 pp | 0.00% +0.000 pp | USD1.93 +0.0% | 1 qtrs NEW |
| 26 | MCIA INC | 63.0K +63.0K (+100.0%) | 141.8K +141.8K (+100.0%) | 0.12% +0.119 pp | 0.02% +0.023 pp | USD1.93 +0.0% | 1 qtrs NEW |
| 27 | STATE STREET CORP | 72.9K +39.2K (+116.3%) | 140.7K +112.8K (+404.4%) | 0.07% -0.247 pp | 0.00% +0.000 pp | USD2.90 -33.4% | 4 qtrs — |
| 28 | BLACKROCK, INC. | 42.7K +— (+0.0%) | 82.5K +47.1K (+133.2%) | 0.04% -0.364 pp | 0.00% +0.000 pp | USD3.79 -49.1% | 6 qtrs — |
| 29 | NORTHERN TRUST CORP | 40.3K +17.3K (+74.9%) | 77.8K +58.7K (+307.9%) | 0.04% -0.179 pp | 0.00% +0.000 pp | USD2.62 -26.3% | 7 qtrs — |
| 30 | PERSISTENT ASSET PARTNERS LTD | 39.6K +39.6K (+100.0%) | 76.4K +76.4K (+100.0%) | 0.04% +0.040 pp | 0.03% +0.034 pp | USD1.93 +0.0% | 1 qtrs NEW |
| 31 | XTX TOPCO LTD | 37.0K +37.0K (+100.0%) | 71.4K +71.4K (+100.0%) | 0.04% +0.037 pp | 0.00% +0.002 pp | USD1.93 +0.0% | 1 qtrs NEW |
| 32 | MORGAN STANLEY | 27.6K +27.5K (+48,312.3%) | 53.3K +53.2K (+113,217.0%) | 0.03% +0.027 pp | 0.00% +0.000 pp | USD1.93 +0.0% | 9 qtrs — |
| 33 | PFG INVESTMENTS, LLC | 21.5K +21.5K (+100.0%) | 41.5K +41.5K (+100.0%) | 0.04% +0.041 pp | 0.00% +0.002 pp | USD1.93 +0.0% | 1 qtrs NEW |
| 34 | VANGUARD PERSONALIZED INDEXING MANAGEMENT, LLC | 12.5K +12.5K (+100.0%) | 24.1K +24.1K (+100.0%) | 0.01% +0.013 pp | 0.00% +0.000 pp | USD1.93 +0.0% | 1 qtrs NEW |
| 35 | CITIGROUP INC | 5.0K +5.0K (+100.0%) | 9.7K +9.7K (+100.0%) | 0.01% +0.005 pp | 0.00% +0.000 pp | USD1.93 +0.0% | 1 qtrs NEW |
| 36 | TOWER RESEARCH CAPITAL LLC (TRC) | 1.4K -353.0 (-20.4%) | 2.7K +1.2K (+85.6%) | 0.00% -0.015 pp | 0.00% +0.000 pp | USD0.77 +150.6% | 9 qtrs — |
| 37 | FORTITUDE FAMILY OFFICE, LLC | 431.00 +431.0 (+100.0%) | 832.00 +832.0 (+100.0%) | 0.00% +0.000 pp | 0.00% +0.000 pp | USD1.93 +0.0% | 1 qtrs NEW |
| 38 | ADVISOR GROUP HOLDINGS, INC. | 384.00 -320.0 (-45.5%) | 741.00 +166.0 (+28.9%) | 0.00% -0.006 pp | 0.00% +0.000 pp | USD2.18 -11.5% | 9 qtrs — |
| 39 | — | 60.00 +60.0 (+100.0%) | 116.00 +116.0 (+100.0%) | 0.00% +0.000 pp | 0.00% +0.000 pp | USD1.92 +0.5% | 1 qtrs NEW |
| 40 | SRS CAPITAL ADVISORS, INC. | 91.00 +— (+0.0%) | 112.00 +36.0 (+47.4%) | 0.00% -0.001 pp | 0.00% +0.000 pp | USD2.42 -20.2% | 9 qtrs — |
| 41 | SBI SECURITIES CO., LTD. | 22.00 +— (+0.0%) | 42.00 +24.0 (+133.3%) | 0.00% 0.000 pp | 0.00% +0.000 pp | USD2.95 -34.6% | 5 qtrs — |
| 42 | SOA WEALTH ADVISORS, LLC. | 13.00 +— (+0.0%) | 25.00 +14.0 (+127.3%) | 0.00% 0.000 pp | 0.00% +0.000 pp | USD1.31 +47.3% | 9 qtrs — |
| 43 | BNP PARIBAS ARBITRAGE, SNC | 5.00 +— (+0.0%) | 10.00 +6.0 (+150.0%) | 0.00% +0.000 pp | 0.00% +0.000 pp | USD1.60 +20.6% | 8 qtrs — |
| 44 | ACTIVEST WEALTH MANAGEMENT | 4.00 +— (+0.0%) | 8.00 +5.0 (+166.7%) | 0.00% +0.000 pp | 0.00% +0.000 pp | USD2.00 -3.5% | 7 qtrs — |
| 45 | JPMORGAN CHASE & CO | 2.00 +— (+0.0%) | 4.00 +2.0 (+100.0%) | 0.00% +0.000 pp | 0.00% +0.000 pp | USD1.00 +93.0% | 9 qtrs — |
| 46 | BARCLAYS PLC | 2.00 +2.0 (+100.0%) | 4.00 +4.0 (+100.0%) | 0.00% +0.000 pp | 0.00% +0.000 pp | USD1.50 +28.7% | 1 qtrs NEW |
| 47 | FINANCIAL GRAVITY ASSET MANAGEMENT, INC. | 2.00 +— (+0.0%) | 4.00 +2.0 (+100.0%) | 0.00% +0.000 pp | 0.00% +0.000 pp | USD0.50 +286.0% | 2 qtrs — |
| 48 | STEWARD PARTNERS INVESTMENT ADVISORY, LLC | 1.00 +— (+0.0%) | 2.00 +1.0 (+100.0%) | 0.00% +0.000 pp | 0.00% +0.000 pp | USD1.00 +93.0% | 9 qtrs — |
| 49 | WELLS FARGO & COMPANY/MN | 1.00 -3.0 (-75.0%) | 2.00 -1.0 (-33.3%) | 0.00% +0.000 pp | 0.00% +0.000 pp | USD1.00 +93.0% | 9 qtrs — |
| 50 | CITY HOLDING CO | — -4.0 (-100.0%) | — -3.0 (-100.0%) | 0.00% +0.000 pp | 0.00% +0.000 pp | USD— | 9 qtrs SOLD |
| 51 | HRT FINANCIAL LP | — -34.2K (-100.0%) | — -28.0K (-100.0%) | 0.00% -0.325 pp | 0.00% 0.000 pp | USD— | 2 qtrs SOLD |
| 52 | SUSQUEHANNA INTERNATIONAL GROUP, LLP | — -44.5K (-100.0%) | — -36.8K (-100.0%) | 0.00% -0.424 pp | 0.00% +0.000 pp | USD— | 4 qtrs SOLD |
| 53 | VIRTU FINANCIAL LLC | — -41.9K (-100.0%) | — -35.0K (-100.0%) | 0.00% -0.399 pp | 0.00% -0.002 pp | USD— | 3 qtrs SOLD |
| 54 | OPALEYE MANAGEMENT INC. | — -375.0K (-100.0%) | — -310.4K (-100.0%) | 0.00% -3.572 pp | 0.00% -0.044 pp | USD— | 8 qtrs SOLD |
| 55 | LYNX1 CAPITAL MANAGEMENT LP | — -1.1M (-100.0%) | — -874.1K (-100.0%) | 0.00% -10.057 pp | 0.00% -0.178 pp | USD— | 8 qtrs SOLD |
| 56 | CITADEL ADVISORS LLC | — -132.0K (-100.0%) | — -109.2K (-100.0%) | 0.00% -1.257 pp | 0.00% +0.000 pp | USD— | 2 qtrs SOLD |
| 57 | TWO SIGMA SECURITIES, LLC | — -45.1K (-100.0%) | — -37.3K (-100.0%) | 0.00% -0.429 pp | 0.00% -0.006 pp | USD— | 3 qtrs SOLD |
Ownership breakdown by holder
ETF Ownership
Top ETFs holding this stock
Held by 12 ETFs in our universe
| # | ETF | Weight | Est. AUM exposure | TER |
|---|---|---|---|---|
| 1 | iShares Micro-Cap ETF IWC | 0.01% | 156.8K | 0.60% |
| 2 | Vanguard Extended Market ETF VXF | 0.00% | 733.1K | 0.05% |
| 3 | Vanguard U.S. Total Market Shares Index ETF VTS.AX | 0.00% | 4.0K | 0.03% |
| 4 | Vanguard U.S. Total Market Index ETF VUN.TO | 0.00% | 11.0K | 0.17% |
| 5 | Vanguard U.S. Total Market Index ETF (CAD-hedged) VUS.TO | 0.00% | 809.04 | 0.17% |
| 6 | Vanguard Total Stock Market ETF VTI | 0.00% | 1.87M | 0.03% |
| 7 | Vanguard All-Equity ETF Portfolio VEQT.TO | 0.00% | 4.1K | 0.22% |
| 8 | Vanguard Growth ETF Portfolio VGRO.TO | 0.00% | 2.2K | 0.22% |
| 9 | Vanguard Balanced ETF Portfolio VBAL.TO | 0.00% | 902.26 | 0.22% |
| 10 | Vanguard Conservative ETF Portfolio VCNS.TO | 0.00% | 99.42 | 0.22% |
Insider Activity
Insider Activity — Latest Quarter
Ratio by transactions
0.00
Bearish
Buys
7
Sells
0
Shares acquired
855.1K
Shares disposed
—
Cash buys
4.00
Cash sales
—
Net activity
+855,105
Insider buys vs sells (history)
From
To
Recent insider transactions
From
To
| Date | Person | Role | Transaction | A/D | Security | Shares | Price | Value | Owned after | D/I | Filing |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-03-26 | Banjak Marc | Officer | P-Purchase | A | Common Stock | 1,434 | 1.76 | 2.5K | 25,000 | D | ↗ |
| 2026-03-19 | Duran Felipe | Officer | P-Purchase | A | Common Stock | 24,835 | 2.02 | 50.1K | 35,974 | D | ↗ |
| 2026-03-19 | Brenner Martin | Director / Officer | P-Purchase | A | Common Stock | 12,336 | 2.02 | 24.9K | 30,652 | D | ↗ |
| 2026-01-28 | Duran Felipe | Officer | A-Award | A | Stock Option (right to buy) | 179,000 | 2.23 | 399.2K | 179,000 | D | ↗ |
| 2026-01-28 | Brenner Martin | Director / Officer | A-Award | A | Stock Option (right to buy) | 479,000 | 2.23 | 1.07M | 479,000 | D | ↗ |
| 2026-01-28 | Banjak Marc | Officer | A-Award | A | Stock Option (right to buy) | 146,000 | 2.23 | 325.6K | 146,000 | D | ↗ |
| 2025-11-20 | Sender Gary | Director | A-Award | A | Stock Option (right to buy) | 13,500 | 1.00 | 13.5K | 13,500 | D | ↗ |
| 2025-11-20 | Schimmelpennink Evert B. | Director | A-Award | A | Stock Option (right to buy) | 13,500 | 1.00 | 13.5K | 13,500 | D | ↗ |
| 2025-11-20 | Parada Antonio Bernardino Guimaraes | Director | A-Award | A | Stock Option (right to buy) | 13,500 | 1.00 | 13.5K | 13,500 | D | ↗ |
| 2025-11-20 | Kropotova Alexandra | Director | A-Award | A | Stock Option (right to buy) | 13,500 | 1.00 | 13.5K | 13,500 | D | ↗ |
| 2025-11-20 | Clark William D | Director | A-Award | A | Stock Option (right to buy) | 13,500 | 1.00 | 13.5K | 13,500 | D | ↗ |
| 2025-11-20 | Arkowitz David | Director | A-Award | A | Stock Option (right to buy) | 13,500 | 1.00 | 13.5K | 13,500 | D | ↗ |
| 2025-10-20 | Duran Felipe | Officer | A-Award | A | Stock Option (right to buy) | 75,000 | 0.89 | 67.0K | 75,000 | D | ↗ |
| 2025-10-20 | Brenner Martin | Director / Officer | A-Award | A | Stock Option (right to buy) | 180,000 | 0.89 | 160.7K | 180,000 | D | ↗ |
| 2025-10-20 | Banjak Marc | Officer | A-Award | A | Stock Option (right to buy) | 55,000 | 0.89 | 49.1K | 55,000 | D | ↗ |
| 2025-02-21 | Duran Felipe | Officer | A-Award | A | Stock Option (right to buy) | 84,700 | 3.48 | 294.8K | 84,700 | D | ↗ |
| 2025-02-21 | Brenner Martin | Director / Officer | A-Award | A | Stock Option (right to buy) | 230,700 | 3.48 | 802.8K | 230,700 | D | ↗ |
| 2025-02-21 | Banjak Marc | Officer | A-Award | A | Stock Option (right to buy) | 71,000 | 3.48 | 247.1K | 71,000 | D | ↗ |
| 2025-01-10 | Sender Gary | Director | P-Purchase | A | Common Stock | 9,191 | 2.72 | 25.0K | 9,191 | D | ↗ |
| 2025-01-10 | Parada Antonio Bernardino Guimaraes | Director | P-Purchase | A | Common Stock | 183,823 | 2.72 | 500.0K | 183,823 | I | ↗ |
| 2025-01-10 | Duran Felipe | Officer | P-Purchase | A | Common Stock | 9,191 | 2.72 | 25.0K | 11,139 | D | ↗ |
| 2025-01-10 | Clark William D | Director | P-Purchase | A | Common Stock | 1,838 | 2.72 | 5.0K | 1,838 | D | ↗ |
| 2025-01-10 | Brenner Martin | Director / Officer | P-Purchase | A | Common Stock | 9,191 | 2.72 | 25.0K | 18,316 | D | ↗ |
| 2025-01-10 | Banjak Marc | Officer | P-Purchase | A | Common Stock | 9,191 | 2.72 | 25.0K | 11,066 | D | ↗ |
| 2025-01-10 | Arkowitz David | Director | P-Purchase | A | Common Stock | 18,382 | 2.72 | 50.0K | 18,382 | D | ↗ |
| 2024-11-21 | Sender Gary | Director | A-Award | A | Stock Option (right to buy) | 18,900 | 2.45 | 46.3K | 18,900 | D | ↗ |
| 2024-11-21 | Schimmelpennink Evert B. | Director | A-Award | A | Stock Option (right to buy) | 18,900 | 2.45 | 46.3K | 18,900 | D | ↗ |
| 2024-11-21 | Parada Antonio Bernardino Guimaraes | Director | A-Award | A | Stock Option (right to buy) | 12,600 | 2.45 | 30.9K | 12,600 | D | ↗ |
| 2024-11-21 | Kropotova Alexandra | Director | A-Award | A | Stock Option (right to buy) | 18,900 | 2.45 | 46.3K | 18,900 | D | ↗ |
| 2024-11-21 | Clark William D | Director | A-Award | A | Stock Option (right to buy) | 18,900 | 2.45 | 46.3K | 18,900 | D | ↗ |
| 2024-11-21 | Arkowitz David | Director | A-Award | A | Stock Option (right to buy) | 12,600 | 2.45 | 30.9K | 12,600 | D | ↗ |
| 2024-08-14 | Banjak Marc | Officer | — | D | Common Stock (RSU) | 0 | 0.00 | — | 1,875 | — | ↗ |
| 2024-05-09 | Duran Felipe | Officer | A-Award | A | Stock Option (right to buy) | 90,000 | 1.88 | 169.2K | 90,000 | — | ↗ |
| 2024-05-09 | Brenner Martin | Officer | A-Award | A | Stock Option (right to buy) | 147,300 | 1.88 | 276.9K | 147,300 | — | ↗ |
| 2024-05-09 | Banjak Marc | Officer | — | D | Stock Option (Right to Buy) | 55,000 | 1.88 | 103.4K | 0 | — | ↗ |
| 2024-04-25 | Duran Felipe | Officer | A-Award | A | Stock Option (right to buy) | 35,800 | 1.72 | 61.6K | 35,800 | — | ↗ |
| 2024-04-25 | Banjak Marc | Officer | — | D | Stock Option (Right to Buy) | 29,000 | 1.72 | 49.9K | 0 | — | ↗ |
| 2023-11-01 | Brenner Martin | Officer | S-Sale | D | Common Stock | 4,881 | 0.27 | 1.3K | 182,502 | — | ↗ |
| 2023-10-03 | Brenner Martin | Officer | S-Sale | D | Common Stock | 5,267 | 0.30 | 1.6K | 187,383 | — | ↗ |
| 2023-10-02 | Brenner Martin | Officer | S-Sale | D | Common Stock | 4,215 | 0.31 | 1.3K | 192,650 | — | ↗ |
| 2023-08-28 | Brenner Martin | Officer | S-Sale | D | Common Stock | 5,011 | 0.31 | 1.5K | 196,865 | — | ↗ |
| 2023-08-23 | Duran Felipe | Officer | A-Award | A | Stock Option (right to buy) | 60,000 | 0.35 | 20.8K | 60,000 | — | ↗ |
| 2023-08-23 | Brenner Martin | Officer | A-Award | A | Stock Option (right to buy) | 120,000 | 0.35 | 41.5K | 120,000 | — | ↗ |
| 2023-08-23 | Banjak Marc | Officer | — | D | Stock Option (Right to Buy) | 3,000 | 6.92 | 20.8K | 0 | — | ↗ |
| 2023-07-27 | Brenner Martin | Officer | S-Sale | D | Common Stock | 35 | 0.51 | 17.85 | 201,876 | — | ↗ |
| 2023-07-12 | Brenner Martin | Officer | S-Sale | D | Common Stock | 47,020 | 0.59 | 27.5K | 206,391 | — | ↗ |
| 2023-06-26 | Brenner Martin | Officer | A-Award | A | Common Stock | 75,833 | 0.00 | — | 253,411 | — | ↗ |
| 2023-06-22 | Brenner Martin | Officer | D-Return | D | Common Stock | 75,833 | 0.00 | — | 177,578 | — | ↗ |
| 2023-06-21 | Brenner Martin | Officer | S-Sale | D | Common Stock | 3,859 | 0.68 | 2.6K | 253,736 | — | ↗ |
| 2023-05-22 | Brenner Martin | Officer | S-Sale | D | Common Stock | 4,158 | 0.94 | 3.9K | 257,619 | — | ↗ |
| 2023-04-24 | Brenner Martin | Officer | S-Sale | D | Common Stock | 4,382 | 1.20 | 5.3K | 261,777 | — | ↗ |
| 2023-03-31 | Duran Felipe | Officer | A-Award | A | Common Stock | 37,500 | 0.00 | — | 39,633 | — | ↗ |
| 2023-03-31 | Brenner Martin | Officer | A-Award | A | Common Stock | 50,000 | 0.00 | — | 266,159 | — | ↗ |
| 2023-03-23 | Brenner Martin | Officer | S-Sale | D | Common Stock | 5,213 | 2.13 | 11.1K | 216,159 | — | ↗ |
| 2023-02-21 | Brenner Martin | Officer | S-Sale | D | Common Stock | 3,976 | 1.77 | 7.0K | 221,372 | — | ↗ |
| 2023-02-13 | Duran Felipe | Officer | — | D | Common Stock (RSU) | 0 | 0.00 | — | 2,133 | — | ↗ |
| 2023-01-20 | Brenner Martin | Officer | A-Award | A | Common Stock | 130,000 | 0.00 | — | 225,348 | — | ↗ |
| 2022-11-11 | Lutz Robert Matthew | Officer | A-Award | A | Common Stock | 100,057 | 0.00 | — | 102,165 | — | ↗ |
| 2022-11-11 | Brenner Martin | Officer | A-Award | A | Common Stock | 95,348 | 0.00 | — | 95,348 | — | ↗ |
| 2022-09-08 | Isett Thomas Francis 3rd | Officer | A-Award | A | Stock Option (right to buy) | 2,000,000 | 0.00 | — | 2,000,000 | — | ↗ |
| 2022-08-29 | Lutz Robert Matthew | Officer | A-Award | A | Stock Option (right to buy) | 400,000 | 0.00 | — | 400,000 | — | ↗ |
| 2022-08-29 | Duran Felipe | Officer | — | D | Stock Option (Right to Buy) | 12,000 | 7.00 | 84.0K | 0 | — | ↗ |
| 2022-08-29 | Brenner Martin | Officer | A-Award | A | Stock Option (right to buy) | 700,000 | 0.00 | — | 700,000 | — | ↗ |
| 2022-08-29 | Banjak Marc | Officer | — | D | Stock Option (Right to Buy) | 600 | 141.20 | 84.7K | 0 | — | ↗ |
| 2022-08-23 | Duran Felipe | Officer | — | D | Stock Option (Right to Buy) | 1,000 | 31.50 | 31.5K | 0 | — | ↗ |
| 2022-05-04 | Duran Felipe | Officer | — | D | Stock Option (Right to Buy) | 2,800 | 32.25 | 90.3K | 0 | — | ↗ |
| 2022-03-10 | Lutz Robert Matthew | Officer | S-Sale | D | Common Stock | 24,625 | 0.35 | 8.5K | 207,375 | — | ↗ |
| 2022-02-21 | Banjak Marc | Officer | — | D | Stock Option (Right to Buy) | 800 | 170.40 | 136.3K | 0 | — | ↗ |
| 2021-12-09 | Sender Gary | Director | A-Award | A | Stock Option (right to buy) | 109,000 | 0.69 | 75.6K | 109,000 | — | ↗ |
| 2021-12-09 | Schimmelpennink Evert B. | Director | A-Award | A | Stock Option (right to buy) | 109,000 | 0.69 | 75.6K | 109,000 | — | ↗ |
| 2021-12-09 | MCKEY JOHN D JR | Director | A-Award | A | Stock Option (right to buy) | 109,000 | 0.69 | 75.6K | 109,000 | — | ↗ |
| 2021-12-09 | Kropotova Alexandra | Director | A-Award | A | Stock Option (right to buy) | 109,000 | 0.69 | 75.6K | 109,000 | — | ↗ |
| 2021-12-09 | GENERAL HILL (Ret) JAMES T. | Director | A-Award | A | Stock Option (right to buy) | 109,000 | 0.69 | 75.6K | 109,000 | — | ↗ |
| 2021-12-09 | Clark William D | Director | A-Award | A | Stock Option (right to buy) | 109,000 | 0.69 | 75.6K | 109,000 | — | ↗ |
| 2021-12-09 | Chang Glenn | Director | A-Award | A | Stock Option (right to buy) | 109,000 | 0.69 | 75.6K | 109,000 | — | ↗ |
| 2021-12-09 | Armstrong Linda Washington | Director | A-Award | A | Stock Option (right to buy) | 109,000 | 0.69 | 75.6K | 109,000 | — | ↗ |
| 2021-12-07 | Maddux Randy Joe | Officer | S-Sale | D | Common Stock | 37,243 | 0.68 | 25.4K | 271,757 | — | ↗ |
| 2021-09-23 | Isett Thomas Francis 3rd | Director / Officer | A-Award | A | Stock Option (right to buy) | 2,000,000 | 1.17 | 2.34M | 2,000,000 | — | ↗ |
| 2021-08-23 | Maddux Randy Joe | Officer | A-Award | A | Stock Option (right to buy) | 500,000 | 1.26 | 630.0K | 500,000 | — | ↗ |
| 2021-08-23 | Lutz Robert Matthew | Officer | A-Award | A | Stock Option (right to buy) | 500,000 | 1.26 | 630.0K | 500,000 | — | ↗ |
| 2021-08-23 | Isett Thomas Francis 3rd | Director / Officer | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2021-08-23 | Clark William D | Director | A-Award | A | Stock Option (right to buy) | 100,000 | 1.26 | 126.0K | 100,000 | — | ↗ |
| 2021-08-23 | Brenner Martin | Officer | A-Award | A | Stock Option (right to buy) | 700,000 | 1.26 | 882.0K | 700,000 | — | ↗ |
| 2021-06-07 | Schimmelpennink Evert B. | Director | A-Award | A | Stock Option | 100,000 | 1.41 | 141.0K | 100,000 | — | ↗ |
| 2021-04-30 | Isett Thomas Francis 3rd | Director / Officer | A-Award | A | Stock Option (right to buy) | 3,000,000 | 1.37 | 4.11M | 3,000,000 | — | ↗ |
| 2021-03-04 | Lutz Robert Matthew | Officer | A-Award | A | Stock Option (right to buy) | 350,000 | 1.43 | 500.5K | 350,000 | — | ↗ |
| 2021-01-18 | Brenner Martin | Officer | A-Award | A | Stock Option | 500,000 | 1.47 | 735.0K | 500,000 | — | ↗ |
| 2020-12-01 | Maddux Randy Joe | Officer | A-Award | A | Stock Option | 465,000 | 1.45 | 674.3K | 465,000 | — | ↗ |
| 2020-10-14 | Sender Gary | Director | A-Award | A | Stock Option | 100,000 | 2.05 | 205.0K | 100,000 | — | ↗ |
| 2020-10-14 | Kropotova Alexandra | Director | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2020-10-14 | Armstrong Linda Washington | Director | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2020-10-01 | Delta John | Officer | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2020-08-11 | Eastern Capital LTD | 10% Owner | S-Sale | D | Common Stock | 15,864,436 | 2.92 | 46.33M | 8,629,693 | — | ↗ |
| 2020-08-10 | Eastern Capital LTD | 10% Owner | S-Sale | D | Common Stock | 7,264,864 | 3.91 | 28.43M | 24,494,129 | — | ↗ |
| 2020-08-07 | Eastern Capital LTD | 10% Owner | C-Conversion | D | Series B Preferred Stock | 5,785 | 0.20 | 1.2K | 0 | — | ↗ |
| 2020-08-06 | Eastern Capital LTD | 10% Owner | S-Sale | D | Common Stock | 2,768,137 | 4.18 | 11.57M | 33,114,597 | — | ↗ |
| 2020-08-05 | Eastern Capital LTD | 10% Owner | S-Sale | D | Common Stock | 900,000 | 4.46 | 4.01M | 35,882,734 | — | ↗ |
| 2020-08-04 | Eastern Capital LTD | 10% Owner | S-Sale | D | Common Stock | 600,000 | 4.39 | 2.64M | 36,782,734 | — | ↗ |
| 2020-06-12 | Kay Robert | Director | A-Award | A | Stock Option | 400,000 | 1.57 | 628.0K | 400,000 | — | ↗ |
| 2020-06-04 | ERWIN ROBERT L | Officer | M-Exempt | D | Stock Option (right to buy) | 28,268 | 0.93 | 26.3K | 108,108 | — | ↗ |
| 2020-06-02 | ERWIN ROBERT L | Officer | M-Exempt | A | Common Stock | 96,124 | 0.93 | 89.4K | 136,376 | — | ↗ |
| 2020-05-27 | Mullaney James P. | Officer | M-Exempt | A | Common Stock | 11,250 | 0.93 | 10.5K | 0 | — | ↗ |
| 2020-04-21 | Isett Thomas Francis 3rd | Director / Officer | A-Award | A | Stock Option (right to buy) | 975,000 | 0.90 | 872.9K | 1,275,000 | — | ↗ |
| 2020-03-19 | Isett Thomas Francis 3rd | Director / Officer | C-Conversion | A | Common Stock | 100,000 | 0.20 | 20.0K | 1,275,000 | — | ↗ |
| 2020-03-17 | Isett Thomas Francis 3rd | Director / Officer | X-InTheMoney | A | Common Stock | 78,024 | 0.22 | 17.2K | 1,275,000 | — | ↗ |
| 2020-03-12 | Isett Thomas Francis 3rd | Director / Officer | A-Award | A | Stock Option (right to buy) | 975,000 | 1.43 | 1.39M | 1,275,000 | — | ↗ |
| 2020-02-20 | Isett Thomas Francis 3rd | Director / Officer | J-Other | D | Series A Warrants (Right to Buy) | 100,000 | 0.22 | 22.0K | 1,275,000 | — | ↗ |
| 2019-10-29 | Isett Thomas Francis 3rd | Director | P-Purchase | A | Series C Convertible Preferred Stock | 20 | 0.20 | 4.00 | 350,000 | — | ↗ |
| 2019-04-01 | RUSSELL PHILIP K. | Director | A-Award | A | Stock Option (right to buy) | 50,000 | 0.90 | 45.0K | 84,500 | — | ↗ |
| 2019-04-01 | MCKEY JOHN D JR | Director | A-Award | A | Stock Option (right to buy) | 50,000 | 0.90 | 45.0K | 94,250 | — | ↗ |
| 2019-04-01 | Kay Robert | Director / Officer | A-Award | A | Stock Option (right to buy) | 50,000 | 0.90 | 45.0K | 357,500 | — | ↗ |
| 2019-04-01 | Isett Thomas Francis 3rd | Director | A-Award | A | Stock Option (right to buy) | 50,000 | 0.90 | 45.0K | 50,000 | — | ↗ |
| 2019-04-01 | GENERAL HILL (Ret) JAMES T. | Director | A-Award | A | Stock Option (right to buy) | 50,000 | 0.90 | 45.0K | 86,750 | — | ↗ |
| 2019-04-01 | FLUG SEYMOUR | Director | A-Award | A | Stock Option (right to buy) | 50,000 | 0.90 | 45.0K | 75,500 | — | ↗ |
| 2019-04-01 | Elliott Arthur Y | Director | A-Award | A | Stock Option (right to buy) | 50,000 | 0.90 | 45.0K | 84,500 | — | ↗ |
| 2019-04-01 | Chang Glenn | Director | A-Award | A | Stock Option (right to buy) | 50,000 | 0.90 | 45.0K | 86,750 | — | ↗ |
| 2019-03-14 | DART KENNETH BRYAN | 10% Owner | J-Other | A | Preferred Stock | 1 | 0.00 | 0.00 | 1 | — | ↗ |
| 2019-02-20 | TERENCE RYAN E | Officer | A-Award | A | Stock Option (right to buy) | 7,500 | 0.93 | 7.0K | 22,500 | — | ↗ |
| 2019-02-20 | RUSSELL PHILIP K. | Director | D-Return | D | Stock Option (right to buy) | 10,000 | 17.20 | 172.0K | 34,500 | — | ↗ |
| 2019-02-20 | Mullaney James P. | Officer | A-Award | A | Stock Option (right to buy) | 11,250 | 0.93 | 10.5K | 11,250 | — | ↗ |
| 2019-02-20 | MCKEY JOHN D JR | Director | A-Award | A | Stock Option (right to buy) | 4,500 | 0.93 | 4.2K | 44,250 | — | ↗ |
| 2019-02-20 | Kay Robert | Director / Officer | D-Return | D | Stock Option (right to buy) | 50,000 | 30.70 | 1.54M | 410,000 | — | ↗ |
| 2019-02-20 | GENERAL HILL (Ret) JAMES T. | Director | D-Return | D | Stock Option (right to buy) | 6,000 | 4.00 | 24.0K | 36,750 | — | ↗ |
| 2019-02-20 | FLUG SEYMOUR | Director | D-Return | D | Stock Option (right to buy) | 6,000 | 7.20 | 43.2K | 25,500 | — | ↗ |
| 2019-02-20 | Elliott Arthur Y | Director | D-Return | D | Stock Option (right to buy) | 6,000 | 4.00 | 24.0K | 34,500 | — | ↗ |
| 2019-02-20 | ERWIN ROBERT L | Officer | D-Return | D | Stock Option (right to buy) | 75,000 | 17.20 | 1.29M | 232,500 | — | ↗ |
| 2019-02-20 | Chang Glenn | Director | D-Return | D | Stock Option (right to buy) | 6,000 | 6.60 | 39.6K | 36,750 | — | ↗ |
| 2019-01-01 | DART KENNETH BRYAN | 10% Owner | J-Other | D | Preferred Stock | 1 | 0.00 | 0.00 | 1 | — | ↗ |
| 2018-07-12 | Eastern Capital LTD | 10% Owner | P-Purchase | A | Common Shares | 2,200,000 | 0.90 | 1.98M | 8,457,734 | — | ↗ |
| 2018-06-26 | Eastern Capital LTD | 10% Owner | P-Purchase | A | Common Shares | 1,683,334 | 0.90 | 1.52M | 6,257,734 | — | ↗ |
| 2017-11-30 | Eastern Capital LTD | 10% Owner | P-Purchase | A | Common Stock | 12,000,000 | 0.20 | 2.40M | 45,744,000 | — | ↗ |
| 2017-05-01 | RUSSELL PHILIP K. | Director | A-Award | A | Stock Option (right to buy) | 60,000 | 0.40 | 24.0K | 460,000 | — | ↗ |
| 2017-05-01 | MCKEY JOHN D JR | Director | A-Award | A | Stock Option (right to buy) | 60,000 | 0.40 | 24.0K | 650,000 | — | ↗ |
| 2017-05-01 | Kay Robert | Director / Officer | A-Award | A | Stock Option (right to buy) | 300,000 | 0.40 | 120.0K | 4,350,000 | — | ↗ |
| 2017-05-01 | GENERAL HILL (Ret) JAMES T. | Director | A-Award | A | Stock Option (right to buy) | 60,000 | 0.40 | 24.0K | 550,000 | — | ↗ |
| 2017-05-01 | FLUG SEYMOUR | Director | A-Award | A | Stock Option (right to buy) | 60,000 | 0.40 | 24.0K | 340,000 | — | ↗ |
| 2017-05-01 | Elliott Arthur Y | Director | A-Award | A | Stock Option (right to buy) | 60,000 | 0.40 | 24.0K | 460,000 | — | ↗ |
| 2017-05-01 | ERWIN ROBERT L | Officer | A-Award | A | Stock Option (right to buy) | 300,000 | 0.40 | 120.0K | 3,350,000 | — | ↗ |
| 2017-05-01 | Chang Glenn | Director | A-Award | A | Stock Option (right to buy) | 60,000 | 0.40 | 24.0K | 550,000 | — | ↗ |
| 2017-03-01 | Mullaney James P. | Officer | — | D | Stock Option (right to buy) | 150,000 | 0.40 | 60.0K | 0 | — | ↗ |
| 2017-02-23 | DART KENNETH BRYAN | 10% Owner | P-Purchase | A | Preferred Stock | 1 | 0.00 | 0.00 | 1 | — | ↗ |
| 2016-04-07 | Eastern Capital LTD | 10% Owner | P-Purchase | A | Common | 6,500,000 | 0.62 | 4.04M | 33,744,000 | — | ↗ |
| 2016-01-25 | Eastern Capital LTD | 10% Owner | X-InTheMoney | A | Common Stock | 1,784,000 | 0.53 | 945.5K | 27,244,000 | — | ↗ |
| 2015-09-04 | TERENCE RYAN E | Officer | A-Award | A | Stock Option (right to buy) | 100,000 | 1.72 | 172.0K | 300,000 | — | ↗ |
| 2015-09-04 | RUSSELL PHILIP K. | Director | A-Award | A | Stock Option (right to buy) | 100,000 | 1.72 | 172.0K | 400,000 | — | ↗ |
| 2015-09-04 | MCKEY JOHN D JR | Director | A-Award | A | Stock Option (right to buy) | 100,000 | 1.72 | 172.0K | 590,000 | — | ↗ |
| 2015-09-04 | Kay Robert | Director / Officer | A-Award | A | Stock Option (right to buy) | 750,000 | 1.72 | 1.29M | 4,050,000 | — | ↗ |
| 2015-09-04 | GIANNONE MARK A | Officer | A-Award | A | Stock Option (right to buy) | 150,000 | 1.72 | 258.0K | 300,000 | — | ↗ |
| 2015-09-04 | GENERAL HILL (Ret) JAMES T. | Director | A-Award | A | Stock Option (right to buy) | 100,000 | 1.72 | 172.0K | 490,000 | — | ↗ |
| 2015-09-04 | FLUG SEYMOUR | Director | A-Award | A | Stock Option (right to buy) | 100,000 | 1.72 | 172.0K | 280,000 | — | ↗ |
| 2015-09-04 | Elliott Arthur Y | Director | A-Award | A | Stock Option (right to buy) | 100,000 | 1.72 | 172.0K | 400,000 | — | ↗ |
| 2015-09-04 | ERWIN ROBERT L | Officer | A-Award | A | Stock Option (right to buy) | 750,000 | 1.72 | 1.29M | 3,050,000 | — | ↗ |
| 2015-09-04 | Chang Glenn | Director | A-Award | A | Stock Option (right to buy) | 100,000 | 1.72 | 172.0K | 490,000 | — | ↗ |
| 2014-09-17 | DESANTIS CARL | 10% Owner | S-Sale | D | Common Stock | 55,700 | 0.76 | 42.3K | 5,751,143 | — | ↗ |
| 2014-09-16 | DESANTIS CARL | 10% Owner | S-Sale | D | Common Stock | 29,880 | 0.63 | 18.8K | 5,806,843 | — | ↗ |
| 2014-09-15 | DESANTIS CARL | 10% Owner | S-Sale | D | Common Stock | 53,130 | 0.60 | 31.9K | 5,836,723 | — | ↗ |
| 2014-09-05 | RUSSELL PHILIP K. | Director | A-Award | A | Stock Option (right to buy) | 60,000 | 0.49 | 29.4K | 300,000 | — | ↗ |
| 2014-09-05 | MCKEY JOHN D JR | Director | A-Award | A | Stock Option (right to buy) | 60,000 | 0.49 | 29.4K | 490,000 | — | ↗ |
| 2014-09-05 | Kay Robert | Director / Officer | A-Award | A | Stock Option (right to buy) | 600,000 | 1.00 | 600.0K | 3,300,000 | — | ↗ |
| 2014-09-05 | GIANNONE MARK A | Officer | A-Award | A | Stock Option (right to buy) | 50,000 | 0.49 | 24.5K | 150,000 | — | ↗ |
| 2014-09-05 | GENERAL HILL (Ret) JAMES T. | Director | A-Award | A | Stock Option (right to buy) | 60,000 | 0.49 | 29.4K | 390,000 | — | ↗ |
| 2014-09-05 | FLUG SEYMOUR | Director | A-Award | A | Stock Option (right to buy) | 60,000 | 0.49 | 29.4K | 180,000 | — | ↗ |
| 2014-09-05 | Elliott Arthur Y | Director | A-Award | A | Stock Option (right to buy) | 60,000 | 0.49 | 29.4K | 300,000 | — | ↗ |
| 2014-09-05 | ERWIN ROBERT L | Officer | A-Award | A | Stock Option (right to buy) | 600,000 | 1.00 | 600.0K | 2,300,000 | — | ↗ |
| 2014-09-05 | Chang Glenn | Director | A-Award | A | Stock Option (right to buy) | 60,000 | 0.49 | 29.4K | 390,000 | — | ↗ |
| 2014-02-03 | DESANTIS CARL | 10% Owner | S-Sale | D | Common Stock | 28,828 | 0.55 | 15.9K | 5,889,853 | — | ↗ |
| 2014-01-31 | DESANTIS CARL | 10% Owner | S-Sale | D | Common Stock | 54,889 | 0.56 | 30.7K | 5,949,314 | — | ↗ |
| 2014-01-30 | DESANTIS CARL | 10% Owner | S-Sale | D | Common Stock | 19,160 | 0.55 | 10.5K | 5,973,570 | — | ↗ |
| 2014-01-29 | DESANTIS CARL | 10% Owner | S-Sale | D | Common Stock | 21,479 | 0.56 | 12.0K | 6,023,363 | — | ↗ |
| 2014-01-28 | DESANTIS CARL | 10% Owner | S-Sale | D | Common Stock | 60,381 | 0.55 | 33.2K | 6,014,209 | — | ↗ |
| 2014-01-24 | GIANNONE MARK A | Officer | A-Award | A | Stock Option (right to buy) | 100,000 | 0.58 | 58.0K | 100,000 | — | ↗ |
| 2014-01-24 | DESANTIS CARL | 10% Owner | S-Sale | D | Common Stock | 46,848 | 0.62 | 29.0K | 6,074,590 | — | ↗ |
| 2013-12-11 | DESANTIS CARL | 10% Owner | S-Sale | D | Common Stock | 30,633 | 0.34 | 10.4K | 6,121,438 | — | ↗ |
| 2013-12-05 | GIANNONE MARK A | Officer | — | D | Common Stock | 0 | 0.00 | — | 22,834 | — | ↗ |
| 2013-10-15 | Eastern Capital LTD | 10% Owner | O-OutOfTheMoney | D | Warrant (right to buy) | 7,500,000 | 0.40 | 3.00M | 0 | — | ↗ |
| 2013-08-13 | DESANTIS CARL | 10% Owner | S-Sale | D | Common Stock | 37,689 | 0.50 | 18.8K | 6,152,071 | — | ↗ |
| 2013-08-08 | DESANTIS CARL | 10% Owner | S-Sale | D | Common Stock | 147,574 | 0.55 | 81.2K | 6,302,721 | — | ↗ |
| 2013-08-07 | DESANTIS CARL | 10% Owner | S-Sale | D | Common Stock | 32,145 | 0.51 | 16.4K | 6,482,010 | — | ↗ |
| 2013-08-06 | DESANTIS CARL | 10% Owner | S-Sale | D | Common Stock | 30,400 | 0.50 | 15.2K | 6,514,155 | — | ↗ |
| 2013-08-05 | DESANTIS CARL | 10% Owner | S-Sale | D | Common Stock | 22,665 | 0.51 | 11.6K | 6,544,555 | — | ↗ |
| 2013-08-02 | DESANTIS CARL | 10% Owner | S-Sale | D | Common Stock | 66,950 | 0.50 | 33.5K | 6,570,220 | — | ↗ |
| 2013-08-01 | DESANTIS CARL | 10% Owner | S-Sale | D | Common Stock | 10,900 | 0.50 | 5.5K | 6,637,170 | — | ↗ |
| 2013-07-31 | DESANTIS CARL | 10% Owner | S-Sale | D | Common Stock | 22,095 | 0.50 | 11.0K | 6,648,070 | — | ↗ |
| 2013-07-30 | DESANTIS CARL | 10% Owner | S-Sale | D | Common Stock | 19,020 | 0.51 | 9.7K | 6,670,165 | — | ↗ |
| 2013-07-29 | DESANTIS CARL | 10% Owner | S-Sale | D | Common Stock | 15,585 | 0.50 | 7.8K | 6,689,185 | — | ↗ |
| 2013-07-26 | DESANTIS CARL | 10% Owner | S-Sale | D | Common Stock | 20,295 | 0.50 | 10.1K | 6,704,770 | — | ↗ |
| 2013-07-25 | DESANTIS CARL | 10% Owner | S-Sale | D | Common Stock | 6,960 | 0.51 | 3.5K | 6,725,065 | — | ↗ |
| 2013-07-23 | DESANTIS CARL | 10% Owner | S-Sale | D | Common Stock | 39,465 | 0.51 | 20.1K | 6,732,025 | — | ↗ |
| 2013-07-19 | DESANTIS CARL | 10% Owner | P-Purchase | A | Common Stock | 1,732,679 | 0.52 | 901.0K | 6,771,490 | — | ↗ |
| 2013-07-15 | RUSSELL PHILIP K. | Director | A-Award | A | Stock Option (right to buy) | 60,000 | 0.52 | 31.2K | 60,000 | — | ↗ |
| 2013-07-15 | MCKEY JOHN D JR | Director | A-Award | A | Stock Option (right to buy) | 60,000 | 0.52 | 31.2K | 60,000 | — | ↗ |
| 2013-07-15 | Kay Robert | Director / Officer | A-Award | A | Stock Option (right to buy) | 300,000 | 0.52 | 156.0K | 300,000 | — | ↗ |
| 2013-07-15 | GENERAL HILL (Ret) JAMES T. | Director | A-Award | A | Stock Option (right to buy) | 60,000 | 0.52 | 31.2K | 60,000 | — | ↗ |
| 2013-07-15 | FLUG SEYMOUR | Director | A-Award | A | Stock Option (right to buy) | 60,000 | 0.52 | 31.2K | 60,000 | — | ↗ |
| 2013-07-15 | Elliott Arthur Y | Director | A-Award | A | Stock Option (right to buy) | 60,000 | 0.52 | 31.2K | 60,000 | — | ↗ |
| 2013-07-15 | ERWIN ROBERT L | Officer | A-Award | A | Stock Option (right to buy) | 300,000 | 0.52 | 156.0K | 300,000 | — | ↗ |
| 2013-07-15 | Chang Glenn | Director | A-Award | A | Stock Option (right to buy) | 60,000 | 0.52 | 31.2K | 60,000 | — | ↗ |
| 2013-04-26 | Eastern Capital LTD | 10% Owner | P-Purchase | A | Common Stock | 4,460,000 | 0.48 | 2.14M | 14,460,000 | — | ↗ |
| 2013-02-21 | Kain Scott | Officer | — | D | Stock Option (right to buy) | 100,000 | 0.66 | 66.0K | 0 | — | ↗ |
| 2013-01-10 | Eastern Capital LTD | 10% Owner | — | D | Warrants (right to buy) | 7,500,000 | 0.88 | 6.60M | 0 | — | ↗ |
Executive team
Top executives
EBIT / Employee
-11.4K
Shares Outstanding
15.79M
Executive compensation
Executive compensation (annual)
| # | Year | Executive | Salary | Bonus | Stock award | Option award | Incentive | Other | Total | % Stock- based |
Filing |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | 2025 | Dr. Martin B. Brenner Chief Executive Officer and Chief Scientific Officer | 539.4K | — | — | 799.3K | 161.4K | 9.9K | 1.51M | 52.94% | ↗ |
| 2 | 2025 | Felipe Duran Chief Financial Officer | 371.3K | — | — | 293.4K | 89.1K | 16.2K | 770.1K | 38.11% | ↗ |
| 3 | 2025 | Marc Banjak Chief Legal Officer | 366.9K | — | — | 246.0K | 88.1K | 11.9K | 712.9K | 34.50% | ↗ |
| 4 | 2024 | Dr. Martin B. Brenner Chief Executive Officer and Chief Scientific Officer | 522.4K | — | — | 518.3K | 208.9K | 21.7K | 1.27M | 40.77% | ↗ |
| 5 | 2024 | Felipe Duran Chief Financial Officer | 360.5K | — | — | 248.6K | 144.2K | 8.5K | 761.9K | 32.64% | ↗ |
| 6 | 2023 | Thomas F. Isett Former Executive Chairman, Former Chief Executive Officer, and Former President | 325.0K | — | 218.7K | 479.4K | 117.0K | 530.5K | 1.67M | 41.79% | ↗ |
| 7 | 2023 | Martin B. Brenner Chief Executive Officer and Chief Scientific Officer | 457.6K | 250.00 | 316.4K | 175.5K | 110.9K | 8.6K | 1.07M | 46.00% | ↗ |
| 8 | 2023 | Dr. Martin B. Brenner Chief Executive Officer and Chief Scientific Officer | 457.6K | 250.00 | 316.4K | 175.5K | 110.9K | 8.6K | 1.07M | 46.00% | ↗ |
| 9 | 2023 | Felipe Duran Chief Financial Officer | 318.8K | 140.3K | 78.0K | 75.2K | 73.1K | 14.3K | 699.7K | 21.90% | ↗ |
| 10 | 2023 | Rob Lutz Former Chief Financial and Business Officer | 273.6K | 250.00 | 175.1K | 100.3K | — | 12.6K | 561.8K | 49.02% | ↗ |
| 11 | 2022 | Thomas F. Isett Executive Chairman, Chief Executive Officer and President | 650.0K | 390.0K | — | 2.01M | — | 16.3K | 3.07M | 65.58% | ↗ |
| 12 | 2022 | Thomas F. Isett Former Executive Chairman, Former Chief Executive Officer, and Former President | 650.0K | — | — | 2.01M | 390.0K | 16.3K | 3.07M | 65.58% | ↗ |
| 13 | 2022 | Martin B. Brenner Chief Executive Officer and Chief Scientific Officer | 405.0K | — | — | 757.9K | 162.0K | 11.3K | 1.34M | 56.72% | ↗ |
| 14 | 2022 | Martin Brenner Chief Scientific Officer | 405.0K | 162.0K | — | 757.9K | — | 11.3K | 1.34M | 56.72% | ↗ |
| 15 | 2022 | Rob Lutz Former Chief Financial and Business Officer | 425.0K | — | — | 541.3K | 170.0K | 21.6K | 1.16M | 46.75% | ↗ |
| 16 | 2022 | Robert Lutz Chief Financial Officer | 425.0K | 170.0K | — | 541.3K | — | 21.6K | 1.16M | 46.75% | ↗ |
| 17 | 2021 | Thomas F. Isett Executive Chairman, Chief Executive Officer and President | 526.1K | 759.5K | — | 3.54M | — | 14.5K | 4.84M | 73.14% | ↗ |
| 18 | 2021 | Thomas F. Isett Executive Chairman, President and Chief Executive Officer | 526.1K | 2.00 | — | 3.54M | — | 2.00 | 4.84M | 73.14% | ↗ |
| 19 | 2021 | Randy Maddux Chief Operating Officer | 230.0K | 5.00 | 448.1K | 584.8K | — | — | 1.52M | 68.04% | ↗ |
| 20 | 2021 | Dr. Martin B. Brenner Chief Scientific Officer | 178.0K | 4.00 | — | 638.3K | — | — | 1.01M | 62.93% | ↗ |
| 21 | 2021 | Martin Brenner Chief Scientific Officer | 178.0K | 198.0K | — | 638.3K | — | — | 1.01M | 62.93% | ↗ |
| 22 | 2021 | Robert Lutz Chief Financial Officer | 133.8K | 60.0K | 331.8K | 432.2K | — | — | 957.7K | 79.77% | ↗ |
| 23 | 2020 | Thomas F. Isett Chairman and Chief Executive Officer | 151.1K | 530.0K | — | 750.5K | — | 352.4K | 1.78M | 42.07% | ↗ |
| 24 | 2020 | Thomas F. Isett Executive Chairman, President and Chief Executive Officer | 151.1K | 3.00 | — | 750.5K | — | 3.00 | 1.76M | 42.57% | ↗ |
| 25 | 2020 | Robert B. Kay Former Chief Executive Officer and Former Co-Chairman, Interim Secretary and Interim Treasurer | 283.0K | — | — | 583.9K | — | 41.7K | 908.6K | 64.27% | ↗ |
| 26 | 2020 | James P. Mullaney Former Chief Financial Officer | 275.0K | 100.0K | — | — | — | 72.4K | 447.4K | 0.00% | ↗ |
| 27 | 2020 | Robert L. Erwin President | 275.0K | — | — | — | — | 16.8K | 291.8K | 0.00% | ↗ |
| 28 | 2019 | James P. Mullaney Former Chief Financial Officer | 269.2K | 50.0K | — | — | — | 66.3K | 385.4K | 0.00% | ↗ |
| 29 | 2019 | Robert B. Kay Former Chief Executive Officer and Former Co-Chairman, Interim Secretary and Interim Treasurer | 300.0K | — | — | 36.9K | — | 40.2K | 377.1K | 9.78% | ↗ |
| 30 | 2019 | Robert B. Kay Executive Chairman and Chief Executive Officer | 310.7K | — | — | 36.9K | — | — | 347.6K | 10.61% | ↗ |
| 31 | 2019 | James P. Mullaney Chief Financial Officer | 269.2K | 50.0K | — | — | — | — | 319.2K | 0.00% | ↗ |
| 32 | 2019 | Robert L. Erwin President | 275.0K | — | — | — | — | 41.1K | 316.1K | 0.00% | ↗ |
| 33 | 2019 | Terence E. Ryan, Ph.D. Chief Scientific Officer | 200.0K | — | — | — | — | — | 200.0K | 0.00% | ↗ |
| 34 | 2018 | Robert B. Kay Executive Chairman | 314.9K | — | — | — | — | — | 314.9K | 0.00% | ↗ |
| 35 | 2018 | Robert B. Kay Executive Chairman and Chief Executive Officer | 314.9K | — | — | — | — | — | 314.9K | 0.00% | ↗ |
| 36 | 2018 | Robert L. Erwin President | 251.7K | — | — | — | — | — | 251.7K | 0.00% | ↗ |
| 37 | 2018 | Robert Erwin President | 251.7K | — | — | — | — | — | 251.7K | 0.00% | ↗ |
| 38 | 2018 | James P. Mullaney Chief Financial Officer | 240.0K | — | — | — | — | — | 240.0K | 0.00% | ↗ |
| 39 | 2018 | James Mullaney Chief Financial Officer | 240.0K | — | — | — | — | — | 240.0K | 0.00% | ↗ |
| 40 | 2018 | Terence E. Ryan, Ph.D. Chief Scientific Officer | 200.0K | — | — | — | — | — | 200.0K | 0.00% | ↗ |
| 41 | 2017 | Robert B. Kay Executive Chairman | 310.7K | — | — | 107.1K | — | — | 417.8K | 25.63% | ↗ |
| 42 | 2017 | Robert Erwin President | 230.0K | — | — | 107.1K | — | — | 337.1K | 31.77% | ↗ |
| 43 | 2017 | Terence E. Ryan, Ph.D. Chief Scientific Officer | 200.0K | — | — | — | — | — | 200.0K | 0.00% | ↗ |
| 44 | 2017 | James Mullaney Chief Financial Officer | 66.7K | 20.0K | — | 53.0K | — | — | 139.6K | 37.93% | ↗ |
| 45 | 2017 | Mark Giannone Former Chief Financial Officer | 112.5K | — | — | — | — | — | 112.5K | 0.00% | ↗ |
| 46 | 2016 | Robert B. Kay Executive Chairman | 310.7K | — | — | 470.5K | — | — | 781.2K | 60.23% | ↗ |
| 47 | 2016 | Robert Erwin President | 230.0K | — | — | 470.5K | — | — | 700.5K | 67.17% | ↗ |
| 48 | 2016 | Terence E. Ryan, Ph.D. Chief Scientific Officer | 200.0K | — | — | 62.7K | — | — | 262.7K | 23.88% | ↗ |
| 49 | 2016 | Mark Giannone Former Chief Financial Officer | 99.0K | — | — | 94.1K | — | — | 193.1K | 48.73% | ↗ |
| 50 | 2015 | Robert B. Kay Executive Chairman | 309.7K | — | — | 239.0K | — | — | 548.7K | 43.55% | ↗ |
| 51 | 2015 | Robert Erwin President | 230.0K | — | — | 238.3K | — | — | 468.3K | 50.88% | ↗ |
| 52 | 2015 | Terence E. Ryan, Ph.D. Chief Scientific Officer | 200.0K | — | — | — | — | — | 200.0K | 0.00% | ↗ |
| 53 | 2015 | Mark Giannone Former Chief Financial Officer | 48.0K | — | — | 21.3K | — | — | 69.3K | 30.70% | ↗ |
| 54 | 2015 | Mark Giannone Chief Financial Officer | 48.0K | — | — | 21.3K | — | — | 69.3K | 30.70% | ↗ |
| 55 | 2014 | Robert B. Kay Executive Chairman | 300.0K | — | — | 132.3K | — | — | 432.3K | 30.60% | ↗ |
| 56 | 2014 | Robert Erwin President | 230.0K | — | — | 132.3K | — | — | 362.3K | 36.51% | ↗ |
| 57 | 2014 | Terence E. Ryan, Ph.D. Chief Scientific Officer | 200.0K | — | — | — | — | — | 200.0K | 0.00% | ↗ |
| 58 | 2014 | Scott Kain Chief Financial Officer | 125.0K | — | — | — | — | — | 125.0K | 0.00% | ↗ |
| 59 | 2014 | Mark Giannone Chief Financial Officer | 22.0K | — | — | 51.2K | — | — | 73.2K | 69.93% | ↗ |
| 60 | 2013 | Robert B. Kay Executive Chairman | 300.0K | — | — | 289.3K | — | — | 589.3K | 49.09% | ↗ |
| 61 | 2013 | Robert Erwin President | 230.0K | — | — | 289.3K | — | — | 519.3K | 55.71% | ↗ |
| 62 | 2013 | Terence E. Ryan, Ph.D. Chief Scientific Officer | 200.0K | — | — | — | — | — | 200.0K | 0.00% | ↗ |
| 63 | 2013 | Douglas J. Beck, CPA Former Chief Financial Officer | 158.1K | — | — | — | — | — | 158.1K | 0.00% | ↗ |
| 64 | 2013 | Scott Kain Chief Financial Officer | 67.5K | — | — | 58.0K | — | — | 125.5K | 46.22% | ↗ |
| 65 | 2013 | Mark Giannone Chief Financial Officer | — | — | — | — | — | — | — | — | ↗ |
| 66 | 2012 | Robert B. Kay Executive Chairman | 300.0K | — | — | 508.9K | — | — | 808.9K | 62.91% | ↗ |
| 67 | 2012 | Robert B. Kay, Executive Chairman and CEO | 300.0K | — | — | 508.9K | — | — | 808.9K | 62.91% | ↗ |
| 68 | 2012 | Robert Erwin, President | 237.5K | — | — | 508.9K | — | — | 746.4K | 68.18% | ↗ |
| 69 | 2012 | Robert Erwin President | 237.5K | — | — | 508.9K | — | — | 746.4K | 68.18% | ↗ |
| 70 | 2012 | Terence E. Ryan, Ph.D. Chief Scientific Officer | 187.5K | — | — | 169.6K | — | — | 357.1K | 47.49% | ↗ |
| 71 | 2012 | Douglas J. Beck, CPA Chief Financial Officer | 165.0K | — | — | — | — | — | 165.0K | 0.00% | ↗ |
| 72 | 2012 | Douglas J. Beck, CPA Former Chief Financial Officer | 165.0K | — | — | — | — | — | 165.0K | 0.00% | ↗ |
| 73 | 2012 | Frederick Larcombe, Chief Financial Officer | — | — | — | — | — | — | — | — | ↗ |
| 74 | 2012 | Scott Kain Chief Financial Officer | — | — | — | — | — | — | — | — | ↗ |
| 75 | 2011 | Robert B. Kay, Executive Chairman and CEO | 250.9K | — | — | 1.89M | — | — | 2.14M | 88.26% | ↗ |
| 76 | 2011 | Robert Erwin, President | 207.7K | — | — | 193.3K | — | — | 401.0K | 48.21% | ↗ |
| 77 | 2011 | Douglas Beck, Chief Financial Officer | 28.8K | — | — | 80.4K | — | — | 109.2K | 73.66% | ↗ |
| 78 | 2011 | Douglas J. Beck, CPA Chief Financial Officer | 28.8K | — | — | 80.4K | — | — | 109.2K | 73.66% | ↗ |
| 79 | 2011 | Frederick Larcombe, Chief Financial Officer | 91.4K | — | — | — | — | — | 91.4K | 0.00% | ↗ |
| 80 | 2010 | Robert Erwin, President | 200.0K | — | — | 28.5K | — | — | 228.5K | 12.46% | ↗ |
| 81 | 2010 | Robert B. Kay, Executive Chairman and CEO | 200.0K | — | — | 28.5K | — | — | 228.5K | 12.46% | ↗ |
| 82 | 2010 | Frederick Larcombe, Chief Financial Officer | 120.3K | — | — | — | — | — | 120.3K | 0.00% | ↗ |
| 83 | 2010 | Douglas Beck, Chief Financial Officer | — | — | — | — | — | — | — | — | ↗ |
| 84 | 2009 | Robert B. Kay, Executive Chairman and CEO | 200.0K | — | — | 2.4K | — | — | 202.4K | 1.20% | ↗ |
| 85 | 2009 | Robert Erwin, President | 200.0K | — | — | 2.4K | — | — | 202.4K | 1.20% | ↗ |
| 86 | 2009 | Dina L. Masi, Former Interim CFO | — | — | — | — | — | 10.3K | 10.3K | 0.00% | ↗ |
| 87 | 2009 | Frederick Larcombe, Chief Financial Officer | — | — | — | — | — | — | — | — | ↗ |
| 88 | 2008 | Robert Erwin, President | 142.3K | 15.4K | — | — | — | — | 157.7K | 0.00% | ↗ |
| 89 | 2008 | Dina L. Masi, Former Interim CFO | — | — | — | — | — | 10.3K | 10.3K | 0.00% | ↗ |
| 90 | 2008 | Robert B. Kay, Executive Chairman and CEO | — | — | — | — | — | 9.3K | 9.3K | 0.00% | ↗ |
CEO compensation breakdown
Proxy statements
Proxy statements (DEF 14A)
| Filing date | Form type | Filing |
|---|---|---|
| 2025-10-06 | DEF 14A | ↗ |
Recent SEC filings
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Martin Brenner | Chief Executive Officer, Chief Scientific Officer & Director | 710.6K | — |
| Felipe Duran | Chief Financial Officer | 476.6K | male |
| Marc Banjak | Chief Legal Officer | 466.9K | male |
| Cory Schwartz | Director of Research and Early Development | — | male |
ESG Rating
ESG Score History BIOTECHNOLOGY
Benchmark vs Sector
Senate Trading Activity
No Senate trading activity found for this company.
House Trading Activity
No House trading activity found for this company.
Market share among peers
Peer comparison — filtered group (TTM)
Your opinion
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for IBIO
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.
